Scarica l'app Stockscreener
187.38
17.88%
28.42
Dopo l'orario di chiusura:
189.00
1.62
+0.86%
Precedente Chiudi:
$158.96
Aprire:
$171.33
Volume 24 ore:
6.85M
Relative Volume:
2.96
Capitalizzazione di mercato:
$32.42B
Reddito:
$15.50B
Utile/perdita netta:
$1.33B
Rapporto P/E:
25.53
EPS:
7.34
Flusso di cassa netto:
$2.16B
1 W Prestazione:
+18.84%
1M Prestazione:
+21.10%
6M Prestazione:
-8.78%
1 anno Prestazione:
-23.59%
Intervallo 1D:
$170.16
$190.13
Intervallo di 1 settimana:
$156.16
$190.13
Portata 52W:
$134.65
$252.88
Iqvia Holdings Inc Stock (IQV) Company Profile
Nome
Iqvia Holdings Inc
Settore
Industria
Telefono
919-998-2000
Indirizzo
2400 ELLIS ROAD, DURHAM, NC
Confronta IQV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-25 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-04-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-12-20 | Iniziato | Stephens | Overweight |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-04 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-07-24 | Downgrade | Jefferies | Buy → Hold |
| 2024-06-06 | Iniziato | Goldman | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-15 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-02-13 | Iniziato | BTIG Research | Buy |
| 2023-11-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-03-17 | Iniziato | Truist | Buy |
| 2022-12-06 | Iniziato | Cowen | Outperform |
| 2022-11-17 | Downgrade | Citigroup | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2022-05-24 | Iniziato | Guggenheim | Buy |
| 2022-04-29 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-16 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-07-07 | Iniziato | Stephens | Equal-Weight |
| 2020-03-02 | Iniziato | Deutsche Bank | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-12-13 | Aggiornamento | CFRA | Sell → Hold |
| 2019-11-14 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Aggiornamento | Mizuho | Neutral → Buy |
| 2019-05-28 | Iniziato | SVB Leerink | Outperform |
| 2019-01-18 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-10-09 | Iniziato | UBS | Buy |
| 2018-10-02 | Reiterato | Robert W. Baird | Outperform |
| 2018-07-25 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Reiterato | Stifel | Buy |
| 2018-07-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-03-07 | Aggiornamento | SunTrust | Hold → Buy |
| 2018-01-19 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Iqvia Holdings Inc Borsa (IQV) Ultime notizie
IQVIA Holdings Reports Strong Q2 2025 Results - TipRanks
IQVIA Q2 2025 Earnings Call Transcript - MarketBeat
IQVIA Stock: Decoding Recent Market Moves - timothysykes.com
IQVIA's Trading Volume Surges 243% to 12.8 Billion, Ranked 67th in Market Activity - AInvest
What drives IQVIA Holdings Inc. stock priceExceptional market performance - Autocar Professional
IQVIA's Q2 Earnings Beat and AI-Driven Growth: Strategic AI Adoption Fuels Resilience in a Volatile Biopharma Market - AInvest
IQVIA: Q2 Earnings Exceeded My Expectations (NYSE:IQV) - Seeking Alpha
Evercore ISI raises IQVIA stock price target to $220 on improved pharma demand - Investing.com Nigeria
IQVIA HOLDINGS INC. SEC 10-Q Report - TradingView
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA leads S&P 500 on strong Q2 earnings, better-than-expected guidance - Sherwood News
U.S. Indexes Finished Mixed Tuesday As IQVIA Holdings Led, Lockheed Martin Lagged - Barron's
What analysts say about IQVIA Holdings Inc. stockHigh-octane investment gains - jammulinksnews.com
IQVIA (IQV) Surpasses Revenue Expectations with Strong Q2 Perfor - GuruFocus
IQVIA Leads S&P 500 Gainers on Better-Than-Expected Earnings - Yahoo Finance
IQVIA: Is It Time to Buy After Recent Price Drop? - timothysykes.com
The CRO Sector's Quiet Revolution: How Medpace and IQVIA Are Leading the Charge - AInvest
IQVIA Holdings (IQV) Updates 2025 Revenue Guidance and Completes Share Buyback - Yahoo Finance
IQVIA: Q2 Earnings Snapshot - CTPost
IQVIA Holdings Inc. Exceeds Q2 Earnings Expectations with $266 Million Net IncomeNews and Statistics - IndexBox
Top Stock Movers Now: GM, Lockheed Martin, IQVIA, DR Horton, and More - 富途牛牛
IQVIA Earnings & Revenues Beat Estimates in Q2, Rise Y/Y - TradingView
Price Target Raised for IQVIA Amid Positive Market Outlook - StocksToTrade
Why IQVIA (IQV) Stock Is Trading Up Today - Yahoo Finance
Evercore Raises IQVIA’s Price Target Amid Market Optimism - timothysykes.com
IQVIA's AI-Driven Growth and Segment Performance in Q2 2025: A Blueprint for Long-Term Healthcare Tech Investment - AInvest
Earnings call transcript: IQVIA Q2 2025 beats expectations, stock surges By Investing.com - Investing.com Nigeria
Earnings call transcript: IQVIA Q2 2025 beats expectations, stock surges - Investing.com India
D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday - inkl
IQVIA Q2 2025 slides: revenue up 5.3%, AI innovation drives growth - Investing.com
IQV Stock Soars Over 16% Boosting Investor Confidence | IQV Stoc - GuruFocus
IQVIA (IQV) Soars After Strong Q2 2025 Earnings - GuruFocus
IQVIA Holdings Beats Forecasts, But Outlook Tightens - Finimize
IQVIA's Resilient Growth in Q2 2025: A Strategic Bet on the Future of Healthcare Data and Life Sciences - AInvest
IQVIA Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
IQVIA shares soar as Q2 results top estimates, outlook strong - Investing.com Australia
Iqvia stock, Medpace stock up after Q2 beats (IQV:NYSE) - Seeking Alpha
IQVIA beats quarterly estimates on resilient demand for healthcare analytics - TradingView
IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
IQVIA Holdings Inc. Updates Earnings Guidance for the Full Year 2025 - MarketScreener
D.R. Horton, Medpace, IQVIA - TradingView
IQVIA Holdings Inc Reports Q2 2025 Revenue of $4.017 Billion, Be - GuruFocus
IQVIA (NYSE:IQV) Beats Q2 Sales Targets, Stock Soars - Yahoo Finance
S&P 500 Futures Decline in Premarket Trading; Medpace Holdings, IQVIA Holdings Lead - Barron's
IQVIA Reports Second-Quarter 2025 Results - TradingView
(IQV) IQVIA Expects Full Year 2025 Revenue Range $16.10B$16.30B, vs. FactSet Est of $16.06B - MarketScreener
IQVIA Holdings earnings beat by $0.04, revenue topped estimates - Investing.com Canada
IQVIA Q2 revenue up 5.3% YoY to $4,017mln, R&D Solutions bookings reach $2.5bln. - AInvest
IQVIA Delivers $4B Quarter: Strong TAS Growth, $32.1B Backlog, and Beats Profit Expectations - Stock Titan
IQVIA Holdings Inc. Stock Analysis and ForecastOver 200% growth - jammulinksnews.com
IQVIA Holdings Inc. Earnings Report: Projections and InsightsNews and Statistics - IndexBox
Iqvia Holdings Inc Azioni (IQV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):